$RZLT
Rezolute, Inc.

2014 Q1 Form 10-Q Financial Statement

#000114420414008442 Filed on February 13, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2012 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.590M $670.0K $1.030M
YoY Change -60.74% -34.95% 312.0%
% of Gross Profit
Research & Development $2.246K $0.00 $0.00
YoY Change -25.75%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.595M $650.1K $500.1K
YoY Change -60.65% 30.01% 100.03%
Operating Profit -$1.595M -$650.1K -$500.1K
YoY Change -60.65% 30.01%
Interest Expense $3.441M $623.3K $109.4K
YoY Change 1794.0% 469.68%
% of Operating Profit
Other Income/Expense, Net -$3.492M -$1.169M -$37.45K
YoY Change 627.91% 3020.31%
Pretax Income -$5.090M -$1.820M -$1.150M
YoY Change 12.36% 58.26% 202.63%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.087M -$1.819M -$537.5K
YoY Change 12.2% 238.34% 41.45%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$39.15M -$14.00M -$6.765M
COMMON SHARES
Basic Shares Outstanding 40.00M shares 40.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.640M $1.140M $0.00
YoY Change 1346.15%
Cash & Equivalents $5.640M $1.140M $0.00
Short-Term Investments
Other Short-Term Assets $120.0K $13.97K
YoY Change -76.0%
Inventory $220.0K $223.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.980M $1.859M $0.00
YoY Change 367.19% -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment $280.0K $280.0K
YoY Change 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $290.0K $286.7K $0.00
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $5.980M $1.859M $0.00
Total Long-Term Assets $290.0K $286.7K $0.00
Total Assets $6.270M $2.146M $0.00
YoY Change 299.36% -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.770M $477.5K $20.00K
YoY Change 126.92% 2287.48% -89.29%
Accrued Expenses $100.0K $600.0K $10.00K
YoY Change -66.67% 5900.0%
Deferred Revenue
YoY Change
Short-Term Debt $890.0K $3.730M $0.00
YoY Change -76.14%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.862M $6.543M $20.00K
YoY Change -44.09% 32612.9% -98.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.862M $6.543M $20.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.860M $6.540M $20.00K
YoY Change -44.14% 32600.0% -98.63%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $14.62K $40.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.408M -$4.397M -$20.00K
YoY Change
Total Liabilities & Shareholders Equity $6.270M $2.146M $0.00
YoY Change 299.38% -100.0%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income -$5.087M -$1.819M -$537.5K
YoY Change 12.2% 238.34% 41.45%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$710.0K -$360.0K -$740.0K
YoY Change 7.58% -51.35% 7300.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$10.00K -$260.0K
YoY Change -100.0% -96.15%
Cash From Investing Activities $0.00 -$10.00K -$260.0K
YoY Change -100.0% -96.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.210M 1.510M 1.310M
YoY Change 1829.63% 15.27%
NET CHANGE
Cash From Operating Activities -710.0K -360.0K -740.0K
Cash From Investing Activities 0.000 -10.00K -260.0K
Cash From Financing Activities 5.210M 1.510M 1.310M
Net Change In Cash 4.500M 1.140M 310.0K
YoY Change 7400.0% 267.74% -3200.0%
FREE CASH FLOW
Cash From Operating Activities -$710.0K -$360.0K -$740.0K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$710.0K -$360.0K -$740.0K
YoY Change 373.33% -51.35% 7300.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Cash
Cash
1144792 USD
CY2013Q4 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
163829 USD
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
10174 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
223000 USD
CY2013Q4 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
165023 USD
CY2013Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
138393 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
275717 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10933 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
477496 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6217894 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-4396749 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2145830 USD
CY2013Q2 us-gaap Assets
Assets
1103971 USD
CY2013Q4 us-gaap Assets
Assets
2145830 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
40000 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
286650 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
40000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3814258 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-4162212 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1103971 USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
163829 USD
CY2013Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
3341 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
223000 USD
CY2013Q2 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
183346 USD
CY2013Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
146037 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
275717 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12705 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
188346 USD
CY2013Q2 us-gaap Interest Payable Current
InterestPayableCurrent
380575 USD
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
601459 USD
CY2013Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
157761 USD
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
663582 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5266183 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6542579 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
8016470 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
10654643 USD
CY2013Q2 us-gaap Cash
Cash
527 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
815549 USD
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
95469 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
13969 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
1859180 USD
CY2013Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3732500 USD
CY2013Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
288422 USD
CY2013Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
807001 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1068206 USD
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3497136 USD
CY2013Q4 antb Consulting Expenses
ConsultingExpenses
80401 USD
CY2011Q2 antb Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
2000000 USD
CY2013Q1 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.882 pure
us-gaap Use Of Estimates
UseOfEstimates
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt">Use of Estimates</font></font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt">&#160;</font></font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives and potential impairment of intangible assets, the fair value of share-based payments, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses.</font></font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q1 us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
35284000 shares
CY2013Q2 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
-157761 USD
antb Fair Value Of Financial Instruments Earnings
FairValueOfFinancialInstrumentsEarnings
505821 USD
CY2013Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
-663582 USD
us-gaap Net Income Loss
NetIncomeLoss
-2638173 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-361602 USD
CY2013Q4 antb Working Capital Deficit
WorkingCapitalDeficit
4683399 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40000000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40000000 shares
CY2013Q1 antb Business Acquisition Purchase Price Allocation Current Assets Inventory1
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory1
223000 USD
CY2013Q1 antb Business Acquisition Purchase Price Allocation Fixed Assets
BusinessAcquisitionPurchasePriceAllocationFixedAssets
264000 USD
CY2013Q1 antb Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill1
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill1
13000 USD
CY2013Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
500000 USD
CY2011Q3 antb Line Of Credit Issued To Related Party
LineOfCreditIssuedToRelatedParty
1000000 USD
CY2013Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
163829 USD
CY2013Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
163829 USD
CY2013Q2 antb Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
3341 USD
CY2013Q4 antb Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
10174 USD
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
The line of credit bears interest equal to the lower of 10%, or the Wall Street Journal Prime Rate (3.25% at December 31, 2013) plus 5%
CY2013Q4 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0825 pure
CY2012 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.05 pure
us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
The line of credit matured on August 31, 2012 and the Company has no further obligations to fund the credit line
antb Consulting Expenses
ConsultingExpenses
179225 USD
antb Consulting Expenses
ConsultingExpenses
162025 USD
CY2012Q4 antb Consulting Expenses
ConsultingExpenses
86574 USD
CY2013Q2 antb Related Party Expenses
RelatedPartyExpenses
807001 USD
CY2013Q4 antb Related Party Expenses
RelatedPartyExpenses
1068206 USD
CY2013Q2 us-gaap Due From Related Parties
DueFromRelatedParties
183346 USD
CY2013Q4 us-gaap Due From Related Parties
DueFromRelatedParties
165023 USD
CY2013Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
3732500 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5152500 USD
CY2013Q4 antb Third Party Capital Investment
ThirdPartyCapitalInvestment
2500000 USD
CY2011Q2 antb Percentage Of Common Share Price Of Financing
PercentageOfCommonSharePriceOfFinancing
0.65 pure
antb Percentage Of Common Share Price Of Financing
PercentageOfCommonSharePriceOfFinancing
0.65 pure
CY2012Q3 antb Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
2000000 USD
CY2012Q4 antb Maximum Convertible Notes Payable Issuance
MaximumConvertibleNotesPayableIssuance
1000000 USD
CY2011Q2 antb Qualified Offering Common Stock
QualifiedOfferingCommonStock
5000000 USD
CY2011Q2 antb Maximum Conversion Pre Money Valuation
MaximumConversionPreMoneyValuation
20000000 USD
CY2011Q2 antb Percentage Of Exercise Per Share On Price Per Common Share
PercentageOfExercisePerShareOnPricePerCommonShare
1.35 pure
CY2012Q3 antb Description Of Convertible Notes
DescriptionOfConvertibleNotes
On the maturity date of the convertible notes, or the closing of a Sale of the Company, whichever occurs first, the lenders are permitted an elective conversion option to convert the outstanding principal and interest on the convertible notes at the lower of 65% of the price per share of common stock in the Qualified Financing or 65% of the common stock price using a pre-money valuation of the Company of $20 million.
CY2012Q4 antb Description Of Convertible Notes
DescriptionOfConvertibleNotes
On the date of a Qualified Financing, the lenders are permitted an elective conversion option to convert the outstanding principal and interest at the lower of 50% of the price per share of common stock in the Qualified Financing or $0.75 per share.
CY2012Q3 antb Percentage Of Price Per Common Share On Warrant To Purchase Two Shares Of Common Stock
PercentageOfPricePerCommonShareOnWarrantToPurchaseTwoSharesOfCommonStock
1.35 pure
CY2012Q4 antb Percentage Of Price Per Common Share On Warrant To Purchase One Share Of Common Stock
PercentageOfPricePerCommonShareOnWarrantToPurchaseOneShareOfCommonStock
1.5 pure
CY2011Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2012Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2010Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2011Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2012Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
110000 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1400000 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
248542 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
710000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9050000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9050000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9050000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6768058 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.75
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
650118 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8317157 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1042948 USD
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.75
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.75
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y1M6D
antb Consulting Fees
ConsultingFees
1062529 USD
antb Consulting Fees
ConsultingFees
228155 USD
antb Consulting Fees
ConsultingFees
162025 USD
CY2012Q4 antb Consulting Fees
ConsultingFees
110514 USD
CY2013Q4 antb Consulting Fees
ConsultingFees
80751 USD
antb Payroll Expenses
PayrollExpenses
5406209 USD
antb Payroll Expenses
PayrollExpenses
393872 USD
antb Payroll Expenses
PayrollExpenses
770332 USD
CY2012Q4 antb Payroll Expenses
PayrollExpenses
193306 USD
CY2013Q4 antb Payroll Expenses
PayrollExpenses
411879 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3494 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap General Insurance Expense
GeneralInsuranceExpense
207947 USD
us-gaap General Insurance Expense
GeneralInsuranceExpense
8616 USD
us-gaap General Insurance Expense
GeneralInsuranceExpense
89077 USD
CY2012Q4 us-gaap General Insurance Expense
GeneralInsuranceExpense
4375 USD
CY2013Q4 us-gaap General Insurance Expense
GeneralInsuranceExpense
44264 USD
us-gaap Professional Fees
ProfessionalFees
1045560 USD
us-gaap Professional Fees
ProfessionalFees
292879 USD
us-gaap Professional Fees
ProfessionalFees
242617 USD
CY2012Q4 us-gaap Professional Fees
ProfessionalFees
138471 USD
CY2013Q4 us-gaap Professional Fees
ProfessionalFees
76968 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
170701 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
34323 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38749 USD
CY2012Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
18531 USD
CY2013Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
25887 USD
antb Travel Expenses
TravelExpenses
246529 USD
antb Travel Expenses
TravelExpenses
55211 USD
antb Travel Expenses
TravelExpenses
7396 USD
CY2012Q4 antb Travel Expenses
TravelExpenses
11630 USD
CY2013Q4 antb Travel Expenses
TravelExpenses
1941 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2067 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1772 USD
CY2012Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2013Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
886 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
172121 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29892 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39053 USD
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23238 USD
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7542 USD
us-gaap Operating Expenses
OperatingExpenses
8317157 USD
us-gaap Operating Expenses
OperatingExpenses
1042948 USD
us-gaap Operating Expenses
OperatingExpenses
1351021 USD
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
500065 USD
antb Proceeds From Issuance Of Notes Payable Related Party
ProceedsFromIssuanceOfNotesPayableRelatedParty
234700 USD
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37449 USD
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1168524 USD
us-gaap Net Income Loss
NetIncomeLoss
-10654643 USD
us-gaap Net Income Loss
NetIncomeLoss
-1168365 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-537514 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-1818642 USD
antb Weighted Average Number Basic And Diluted Shares Outstanding
WeightedAverageNumberBasicAndDilutedSharesOutstanding
36415569 shares
antb Weighted Average Number Basic And Diluted Shares Outstanding
WeightedAverageNumberBasicAndDilutedSharesOutstanding
35284000 shares
antb Weighted Average Number Basic And Diluted Shares Outstanding
WeightedAverageNumberBasicAndDilutedSharesOutstanding
40000000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
-1351021 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-500065 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-650118 USD
antb Interest Income
InterestIncome
144424 USD
antb Interest Income
InterestIncome
88902 USD
antb Interest Income
InterestIncome
6833 USD
CY2012Q4 antb Interest Income
InterestIncome
71972 USD
CY2013Q4 antb Interest Income
InterestIncome
3379 USD
us-gaap Interest Expense
InterestExpense
1818328 USD
us-gaap Interest Expense
InterestExpense
214319 USD
us-gaap Interest Expense
InterestExpense
788164 USD
CY2012Q4 us-gaap Interest Expense
InterestExpense
109421 USD
CY2013Q4 us-gaap Interest Expense
InterestExpense
623347 USD
us-gaap Other General Expense
OtherGeneralExpense
663582 USD
us-gaap Other General Expense
OtherGeneralExpense
0 USD
us-gaap Other General Expense
OtherGeneralExpense
505821 USD
CY2012Q4 us-gaap Other General Expense
OtherGeneralExpense
0 USD
CY2013Q4 us-gaap Other General Expense
OtherGeneralExpense
548556 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2337486 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-125417 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1287152 USD
CY2012Q4 antb Weighted Average Number Basic And Diluted Shares Outstanding
WeightedAverageNumberBasicAndDilutedSharesOutstanding
35284000 shares
CY2013Q4 antb Weighted Average Number Basic And Diluted Shares Outstanding
WeightedAverageNumberBasicAndDilutedSharesOutstanding
40000000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.75
CY2013Q1 antb Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Immediately
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedImmediately
4916667 shares
CY2013Q2 antb Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Immediately
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedImmediately
12500 shares
CY2013Q1 antb Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Monthly
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedMonthly
3250000 shares
CY2013Q1 antb Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Monthly Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedMonthlyTerm
P3Y
CY2013Q2 antb Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod
833333 shares
us-gaap Share Based Compensation
ShareBasedCompensation
330636 USD
CY2013Q4 us-gaap Share Based Compensation
ShareBasedCompensation
165318 USD
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1352452 USD
CY2013Q2 antb Class Of Warrant Value
ClassOfWarrantValue
157761 USD
CY2013Q4 antb Class Of Warrant Value
ClassOfWarrantValue
95964 USD
CY2013Q4 antb Fair Value Of Class Of Warrants
FairValueOfClassOfWarrants
191126 USD
CY2012Q2 antb Proceeds From Issuance Of Stock Option To Purchase Of Common Stock
ProceedsFromIssuanceOfStockOptionToPurchaseOfCommonStock
3500000 shares
CY2010Q1 us-gaap Stockholders Equity
StockholdersEquity
100 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3687502 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
330636 USD
CY2013 antb Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
191126 USD
antb Class Of Warrant Or Right Expense
ClassOfWarrantOrRightExpense
189292 USD
CY2013 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-24470 USD
us-gaap Net Income Loss
NetIncomeLoss
-505630 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-783383 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-6727457 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
-505530 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
-1288913 USD
us-gaap Profit Loss
ProfitLoss
-10654643 USD
us-gaap Profit Loss
ProfitLoss
-1168365 USD
us-gaap Profit Loss
ProfitLoss
-2638173 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
705136 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17029 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
346366 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
289150 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
1066066 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 USD
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
10174 USD
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-723 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
417636 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
511733 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
87429 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
149644 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4018138 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
88969 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
120000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-81500 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
188286 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
15868 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-18323 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
478529 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
261205 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
601459 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
109861 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
220884 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2885188 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-743548 USD
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
11717 USD
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
0 USD
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
0 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
500000 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0 USD
us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
6833 USD
antb Proceeds From Issuance Of Notes Receivable Related Party
ProceedsFromIssuanceOfNotesReceivableRelatedParty
-1138057 USD
antb Proceeds From Issuance Of Notes Receivable Related Party
ProceedsFromIssuanceOfNotesReceivableRelatedParty
-283128 USD
antb Proceeds From Issuance Of Notes Receivable Related Party
ProceedsFromIssuanceOfNotesReceivableRelatedParty
0 USD
antb Payment To Acquire Notes Receivable Related Parties
PaymentToAcquireNotesReceivableRelatedParties
-974228 USD
antb Payment To Acquire Notes Receivable Related Parties
PaymentToAcquireNotesReceivableRelatedParties
-23378 USD
antb Payment To Acquire Notes Receivable Related Parties
PaymentToAcquireNotesReceivableRelatedParties
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-685720 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-259027 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6833 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
384000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
145000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
142000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4900500 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1450000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1420000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
35500 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4715700 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1305000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1512700 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1144792 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
302425 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1144265 USD
CY2010Q1 us-gaap Cash
Cash
0 USD
CY2012Q2 us-gaap Cash
Cash
25878 USD
CY2012Q4 us-gaap Cash
Cash
328303 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
1207 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
antb Assumption Of Related Party In Reverse Merger
AssumptionOfRelatedPartyInReverseMerger
23263 USD
antb Assumption Of Related Party In Reverse Merger
AssumptionOfRelatedPartyInReverseMerger
0 USD
antb Assumption Of Related Party In Reverse Merger
AssumptionOfRelatedPartyInReverseMerger
0 USD
us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
223000 USD
us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
264000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
13000 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 USD
antb Cash Paid For Asset Acquisition
CashPaidForAssetAcquisition
500000 USD
antb Cash Paid For Asset Acquisition
CashPaidForAssetAcquisition
0 USD
antb Cash Paid For Asset Acquisition
CashPaidForAssetAcquisition
0 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
ANTB
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40000000 shares
dei Entity Registrant Name
EntityRegistrantName
AntriaBio, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001509261
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
0 USD
CY2013Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
234700 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
1883708 USD
antb Proceeds From Issuance Of Notes Payable Related Party
ProceedsFromIssuanceOfNotesPayableRelatedParty
0 USD
antb Proceeds From Issuance Of Notes Payable Related Party
ProceedsFromIssuanceOfNotesPayableRelatedParty
234700 USD
antb Fair Value Of Warrants
FairValueOfWarrants
218406 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
189292 USD

Files In Submission

Name View Source Status
0001144204-14-008442-index-headers.html Edgar Link pending
0001144204-14-008442-index.html Edgar Link pending
0001144204-14-008442.txt Edgar Link pending
0001144204-14-008442-xbrl.zip Edgar Link pending
antb-20131231.xml Edgar Link completed
antb-20131231.xsd Edgar Link pending
antb-20131231_cal.xml Edgar Link unprocessable
antb-20131231_def.xml Edgar Link unprocessable
antb-20131231_lab.xml Edgar Link unprocessable
antb-20131231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tex10-2_header.jpg Edgar Link pending
v366819_10q.htm Edgar Link pending
v366819_ex10-1.htm Edgar Link pending
v366819_ex10-2.htm Edgar Link pending
v366819_ex31-1.htm Edgar Link pending
v366819_ex32-1.htm Edgar Link pending